- Home
- DTIL vs VRCA Comparison
DTIL vs VRCA Comparison
Compare DTIL & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- VRCA
- Stock Information
- Founded
- DTIL 2006
- VRCA 2013
- Country
- DTIL United States
- VRCA United States
- Employees
- DTIL N/A
- VRCA N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- DTIL Health Care
- VRCA Health Care
- Exchange
- DTIL Nasdaq
- VRCA Nasdaq
- Market Cap
- DTIL 51.6M
- VRCA 43.0M
- IPO Year
- DTIL 2019
- VRCA 2018
- Fundamental
- Price
- DTIL $5.09
- VRCA $0.54
- Analyst Decision
- DTIL Strong Buy
- VRCA Hold
- Analyst Count
- DTIL 2
- VRCA 5
- Target Price
- DTIL $47.00
- VRCA $6.00
- AVG Volume (30 Days)
- DTIL 74.8K
- VRCA 263.8K
- Earning Date
- DTIL 05-15-2025
- VRCA 05-13-2025
- Dividend Yield
- DTIL N/A
- VRCA N/A
- EPS Growth
- DTIL N/A
- VRCA N/A
- EPS
- DTIL N/A
- VRCA N/A
- Revenue
- DTIL $51,141,000.00
- VRCA $7,179,000.00
- Revenue This Year
- DTIL N/A
- VRCA $127.85
- Revenue Next Year
- DTIL $30.20
- VRCA $105.09
- P/E Ratio
- DTIL N/A
- VRCA N/A
- Revenue Growth
- DTIL N/A
- VRCA N/A
- 52 Week Low
- DTIL $3.61
- VRCA $0.38
- 52 Week High
- DTIL $13.32
- VRCA $9.36
- Technical
- Relative Strength Index (RSI)
- DTIL 49.26
- VRCA 43.40
- Support Level
- DTIL $4.72
- VRCA $0.49
- Resistance Level
- DTIL $5.10
- VRCA $0.73
- Average True Range (ATR)
- DTIL 0.26
- VRCA 0.07
- MACD
- DTIL 0.01
- VRCA -0.01
- Stochastic Oscillator
- DTIL 50.16
- VRCA 10.77
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.